Interview with Dr Art Krieg, CEO, Checkmate Pharmaceuticals
World leading! - Longest established – 15th Annual in 2016 - Largest – 200+ speakers, 750+ attendees, 65+ exhibitors - More decision-makers – 77% Director level+ For Phacilitate, Cell & Gene Therapy World 2016 is all about building on this position of strength to deliver the undisputed leader in novel biologics industry events worldwide. o Significantly larger expo & 121 Partnering Area offers more Private Meeting Booths o Innovation Accelerator Theatre - brings key topics to the expo floor o Regional Pavilions - learn more about the partnering and financing opportunities in all parts of the globe o Japanese Executive Summit - novel regulatory pathways have opened up Japan, find out how to capitalise on these changes in this dedicated stream o Expanded agenda – more in-depth coverage of the key manufacturing, logistical, R&D and regulatory challenges and solutions o More interactive formats – ‘Interactive Hours’ every day, Tech Room Demonstrations, Roundtables, ‘Drop-in Clinics’ and more. o Stars of the Future – new feature welcomes the next generation of innovation and talent to join in the debate shaping the future of the Cell & Gene Therapy and Immunotherapy industries. Guarantee your place, optimize your involvement, maximize your ROI. Contact Phacilitate today to find out how you can be a part of this exciting event on email@example.com
Where will you get a chance to meet and shake the hand of the top clinical leaders from across the immuno-oncology world? The true business leaders? The immuno-oncology deal frenzy rolls on and where will you be when they look to invest in a checkpoint technology or co-stimulatory pathway? Can you make their portfolio more efficient through cost-cutting, global clinical trial services? This coming January, Phacilitate will bring together 750 deal makers to discuss the direction, future and value of cell, gene and immunotherapy portfolios. With keynote speakers from all the organisations to currently have checkpoint inhibitors in the marketplace, this is one event you do not want to miss. Join 80+ visionary speakers from across the field of immuno-oncology for unprecedented strategic knowledge exchange and benchmarking opportunities.
Join the most senior oncology event in the pharmaceutical sector where 88% of the audience are Director-level and above for two days of strategic thinking and networking. Recognized as the leader by the leaders, the Oncology Leaders Forum is the event of choice for senior translational and clinical oncology R&D executives driving the development, registration and launch of novel cancer therapeutics of all classes, plus companion diagnostics. In 2016 we will be taking a hard look at recent trends, successes and failures, delivering invaluable insights into what the next strategic steps should be to drive the successful oncology therapeutics of tomorrow into and through the clinic. Would you like to be part of the illustrious speaking panel at this event? If so contact Phacilitate now to find out how you can be involved on firstname.lastname@example.org.
Meet all the key stakeholders under one roof: Pharma, Biotech, CROs, Health Systems, CMOs and Government! Key themes will include: Integrating big data across drug development; big data in translational science and clinical trials; precision medicine analytics ecosystem; big data enabling the future of healthcare. Find out how you can be a part of this exciting new event by contacting Phacilitate now on email@example.com.
Following on from the sell-out success of Cell & Gene Therapy Europe 2015, join Phacilitate at the second edition in Berlin in 2016. The premier event for Europe's cell and gene therapy community will offer attendees the opportunity to network, share best practice and learn from other leaders across the cell and gene therapy sector. Launching alongside Cell & Gene Therapy Europe will be Immunotherapy Europe 2016, so to find out how you can be part of this exciting, expanding event contact the Phacilitate team now on firstname.lastname@example.org.
Phacilitate are launching Immunotherapy Europe in Berlin in September 2016 alongside Cell & Gene Therapy Europe. Immuno-oncology is the hot topic across the life science sector following a slew of recent successes and approvals. Meet leaders from across the sector to discover the path to commercialization in Europe. Be part of this exciting new event from the start! To find out how contact Phacilitate on email@example.com now.
Interview with Taylor Schreiber, M.D. Ph.D., Chief Scientific Officer Heat Biologics, Inc.
Interview with Dr David Sourdive, Executive Vice President, Corporate Development, Cellectis
Interview with Alexandra Glucksmann, Chief Operating Officer, Editas Medicine
Interview wiht Edward Lanphier, President & Chief Executive Officer, Sangamo BioSciences, Inc. / President, Alliance for Regenerative Medicine (ARM)